Detalhe da pesquisa
1.
Steroid-free combination of 5-azacytidine and venetoclax for the treatment of multiple myeloma.
Haematologica
; 2024 03 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38511268
2.
ADAM22/LGI1 complex as a new actionable target for breast cancer brain metastasis.
BMC Med
; 18(1): 349, 2020 11 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33208158
3.
The RNA processing factors THRAP3 and BCLAF1 promote the DNA damage response through selective mRNA splicing and nuclear export.
Nucleic Acids Res
; 45(22): 12816-12833, 2017 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29112714
4.
An investigation of Sigma-1 receptor expression and ligand-induced endoplasmic reticulum stress in breast cancer.
Cancer Gene Ther
; 30(2): 368-374, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36352093
5.
Predictive modelling of response to neoadjuvant therapy in HER2+ breast cancer.
NPJ Breast Cancer
; 9(1): 72, 2023 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37758711
6.
Mapping molecular subtype specific alterations in breast cancer brain metastases identifies clinically relevant vulnerabilities.
Nat Commun
; 13(1): 514, 2022 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35082299
7.
A clinically compatible drug-screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis.
EMBO Mol Med
; 14(3): e14552, 2022 03 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35174975
8.
Comparative analysis of the AIB1 interactome in breast cancer reveals MTA2 as a repressive partner which silences E-Cadherin to promote EMT and associates with a pro-metastatic phenotype.
Oncogene
; 40(7): 1318-1331, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33420368
9.
Transcriptome Characterization of Matched Primary Breast and Brain Metastatic Tumors to Detect Novel Actionable Targets.
J Natl Cancer Inst
; 111(4): 388-398, 2019 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29961873
10.
Correction to: An investigation of Sigma-1 receptor expression and ligand-induced endoplasmic reticulum stress in breast cancer.
Cancer Gene Ther
; 30(2): 389, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36539529
11.
Dynamic epi-transcriptomic landscape mapping with disease progression in estrogen receptor-positive breast cancer.
Cancer Commun (Lond)
; 43(5): 615-619, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36670046
12.
Epigenome-wide SRC-1-Mediated Gene Silencing Represses Cellular Differentiation in Advanced Breast Cancer.
Clin Cancer Res
; 24(15): 3692-3703, 2018 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29567811
13.
Network analysis of SRC-1 reveals a novel transcription factor hub which regulates endocrine resistant breast cancer.
Oncogene
; 37(15): 2008-2021, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29367763